These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 38673905)

  • 1. Exploring Advanced Therapies for Primary Biliary Cholangitis: Insights from the Gut Microbiota-Bile Acid-Immunity Network.
    Guo Z; He K; Pang K; Yang D; Lyu C; Xu H; Wu D
    Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38673905
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bile acids and intestinal microbiota in autoimmune cholestatic liver diseases.
    Li Y; Tang R; Leung PSC; Gershwin ME; Ma X
    Autoimmun Rev; 2017 Sep; 16(9):885-896. PubMed ID: 28698093
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comprehensive Analysis of Serum and Fecal Bile Acid Profiles and Interaction with Gut Microbiota in Primary Biliary Cholangitis.
    Chen W; Wei Y; Xiong A; Li Y; Guan H; Wang Q; Miao Q; Bian Z; Xiao X; Lian M; Zhang J; Li B; Cao Q; Fan Z; Zhang W; Qiu D; Fang J; Gershwin ME; Yang L; Tang R; Ma X
    Clin Rev Allergy Immunol; 2020 Feb; 58(1):25-38. PubMed ID: 30900136
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The gut microbial influence on cholestatic liver disease.
    Kummen M; Hov JR
    Liver Int; 2019 Jul; 39(7):1186-1196. PubMed ID: 31125502
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The fecal microbiota of patients with primary biliary cholangitis (PBC) causes PBC-like liver lesions in mice and exacerbates liver damage in a mouse model of PBC.
    Jiang H; Yu Y; Hu X; Du B; Shao Y; Wang F; Chen L; Yan R; Li L; Lv L
    Gut Microbes; 2024; 16(1):2383353. PubMed ID: 39105259
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PPAR-Mediated Bile Acid Glucuronidation: Therapeutic Targets for the Treatment of Cholestatic Liver Diseases.
    Gallucci GM; Hayes CM; Boyer JL; Barbier O; Assis DN; Ghonem NS
    Cells; 2024 Aug; 13(15):. PubMed ID: 39120326
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of Microbes on the Pathogenesis of Primary Biliary Cirrhosis (PBC) and Primary Sclerosing Cholangitis (PSC).
    Mattner J
    Int J Mol Sci; 2016 Nov; 17(11):. PubMed ID: 27834858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical Management of Primary Biliary Cholangitis-Strategies and Evolving Trends.
    Gao L; Wang L; Woo E; He X; Yang G; Bowlus C; Leung PSC; Gershwin ME
    Clin Rev Allergy Immunol; 2020 Oct; 59(2):175-194. PubMed ID: 31713023
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bile Acids and the Potential Role in Primary Biliary Cirrhosis.
    Yang H; Duan Z
    Digestion; 2016; 94(3):145-153. PubMed ID: 27832649
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-fat diet modulates bile acid composition and gut microbiota, affecting severe cholangitis and cirrhotic change in murine primary biliary cholangitis.
    Umemura M; Honda A; Yamashita M; Chida T; Noritake H; Yamamoto K; Honda T; Ichimura-Shimizu M; Tsuneyama K; Miyazaki T; Kurono N; Leung PSC; Gershwin ME; Suda T; Kawata K
    J Autoimmun; 2024 Sep; 148():103287. PubMed ID: 39033687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alterations in microbiota and their metabolites are associated with beneficial effects of bile acid sequestrant on icteric primary biliary Cholangitis.
    Li B; Zhang J; Chen Y; Wang Q; Yan L; Wang R; Wei Y; You Z; Li Y; Miao Q; Xiao X; Lian M; Chen W; Qiu D; Fang J; Gershwin ME; Tang R; Ma X
    Gut Microbes; 2021; 13(1):1946366. PubMed ID: 34437819
    [No Abstract]   [Full Text] [Related]  

  • 12. Current Landscape and Evolving Therapies for Primary Biliary Cholangitis.
    Fiorucci S; Urbani G; Di Giorgio C; Biagioli M; Distrutti E
    Cells; 2024 Sep; 13(18):. PubMed ID: 39329760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Primary biliary cholangitis and bile acid metabolism].
    Wang L; Han YC; Han Y
    Zhonghua Gan Zang Bing Za Zhi; 2017 Nov; 25(11):874-877. PubMed ID: 29325285
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting the Gut Microbiome as a Treatment for Primary Sclerosing Cholangitis: A Conceptional Framework.
    Shah A; Macdonald GA; Morrison M; Holtmann G
    Am J Gastroenterol; 2020 Jun; 115(6):814-822. PubMed ID: 32250997
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The challenges of primary biliary cholangitis: What is new and what needs to be done.
    Terziroli Beretta-Piccoli B; Mieli-Vergani G; Vergani D; Vierling JM; Adams D; Alpini G; Banales JM; Beuers U; Björnsson E; Bowlus C; Carbone M; Chazouillères O; Dalekos G; De Gottardi A; Harada K; Hirschfield G; Invernizzi P; Jones D; Krawitt E; Lanzavecchia A; Lian ZX; Ma X; Manns M; Mavilio D; Quigley EM; Sallusto F; Shimoda S; Strazzabosco M; Swain M; Tanaka A; Trauner M; Tsuneyama K; Zigmond E; Gershwin ME
    J Autoimmun; 2019 Dec; 105():102328. PubMed ID: 31548157
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gut microbiota translocation promotes autoimmune cholangitis.
    Ma HD; Zhao ZB; Ma WT; Liu QZ; Gao CY; Li L; Wang J; Tsuneyama K; Liu B; Zhang W; Zhou Y; Gershwin ME; Lian ZX
    J Autoimmun; 2018 Dec; 95():47-57. PubMed ID: 30340822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The gut microbiota-bile acid axis in cholestatic liver disease.
    Sun D; Xie C; Zhao Y; Liao J; Li S; Zhang Y; Wang D; Hua K; Gu Y; Du J; Huang G; Huang J
    Mol Med; 2024 Jul; 30(1):104. PubMed ID: 39030473
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gut microbiome in primary sclerosing cholangitis: A review.
    Little R; Wine E; Kamath BM; Griffiths AM; Ricciuto A
    World J Gastroenterol; 2020 Jun; 26(21):2768-2780. PubMed ID: 32550753
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Secretin alleviates biliary and liver injury during late-stage primary biliary cholangitis via restoration of secretory processes.
    Kennedy L; Carpino G; Owen T; Ceci L; Kundu D; Meadows V; Kyritsi K; Franchitto A; Onori P; Isidan A; Zhang W; Ekser B; Alvaro D; Gaudio E; Gershwin ME; Francis H; Glaser S; Alpini G
    J Hepatol; 2023 Jan; 78(1):99-113. PubMed ID: 35987275
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intestinal microbiota in biliary diseases.
    Xia Q; Liu Q; Ma X
    Curr Opin Gastroenterol; 2023 Mar; 39(2):95-102. PubMed ID: 36821457
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.